1. Home
  2. BMA vs INDV Comparison

BMA vs INDV Comparison

Compare BMA & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco Macro S.A.  ADR (representing Ten Class B)

BMA

Banco Macro S.A. ADR (representing Ten Class B)

HOLD

Current Price

$81.95

Market Cap

4.4B

Sector

Finance

ML Signal

HOLD

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$31.88

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMA
INDV
Founded
1966
N/A
Country
Argentina
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.7B
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
BMA
INDV
Price
$81.95
$31.88
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$96.75
N/A
AVG Volume (30 Days)
279.6K
1.9M
Earning Date
05-27-2026
06-08-2026
Dividend Yield
4.00%
N/A
EPS Growth
N/A
8100.00
EPS
N/A
1.64
Revenue
N/A
$1,239,000,000.00
Revenue This Year
$16.25
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$33.22
$19.23
Revenue Growth
N/A
4.29
52 Week Low
$38.30
$8.69
52 Week High
$106.15
$38.00

Technical Indicators

Market Signals
Indicator
BMA
INDV
Relative Strength Index (RSI) 60.76 53.21
Support Level $64.88 $31.70
Resistance Level $94.54 $32.42
Average True Range (ATR) 3.37 1.20
MACD 1.12 0.29
Stochastic Oscillator 90.25 67.54

Price Performance

Historical Comparison
BMA
INDV

About BMA Banco Macro S.A. ADR (representing Ten Class B)

Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: